Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Noramidopyrine chewable tablets for dog or cat

The technology of analgin and chewable tablets is applied in the field of preparation of veterinary drugs, which can solve problems such as poor palatability, and achieve the effects of reducing waste and improving the cure rate.

Inactive Publication Date: 2008-06-04
TIANJIN RINGPU BIO TECH
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] Aiming at the physiological characteristics of dogs and cats, the inventor broke through the shortcomings of poor palatability of existing tablets, and developed a chewable tablet suitable for dogs and cats, which can be fully chewed and absorbed, effectively improving the utilization rate of therapeutic drugs , Guaranteed the dosage and improved the cure rate of dog and cat diseases

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0018] Example 1: Analgin chewable tablets

[0019] Take 2400g of starch and bake at 100°C for 1 hour and cool to room temperature; take another 1800g of Analgin and 60g of aspartame, dilute and mix with the cooled starch in equal increments dilution method, then pass through 60 mesh, finely sieve Mixture A was obtained three times. Put mixture A with 600 g of oral glucose, 600 g of skimmed milk powder and 540 g of starch into a mixer and mix evenly to obtain a mixture B for use. Mix glycerin and anhydrous ethanol in a ratio of 1:10 and take 2.5L, and add 200 g of polyvinylpyrrolidone to make a polyvinylpyrrolidone glycerol-ethanol mixed solution.

[0020] Under stirring, add the polyvinylpyrrolidone glycerol-ethanol mixed solution to the mixture B in portions until all the additions are completed, and a soft material with uniform mixing and moderate humidity is obtained. Granulate with 16 mesh sieve, ventilate and dry at 50℃. Accurately weigh 60g of magnesium stearate and add it ...

Embodiment 2

[0028] Example 2: Analgin chewable tablets

[0029] Mix 2400g starch, 2190g diazepam, and 180g aspartame to prepare mixture A according to the method described in Example 1.

[0030] Put mixture A, 375 g of oral glucose, 1125 g of skimmed milk powder and 30 g of starch into a mixer and mix evenly to obtain a mixture B, which is ready for use. Mix glycerin and anhydrous ethanol in a ratio of 1:5 and take 2.5L, add 200g of polyvinylpyrrolidone to it to make a polyvinylpyrrolidone glycerol-ethanol mixed solution as a binder.

[0031] Under stirring, add the polyvinylpyrrolidone glycerol-ethanol mixed solution to the mixture B in portions until all the additions are completed, and a soft material with uniform mixing and moderate humidity is obtained. Accurately weigh 30 g of magnesium stearate into granules, and granulate, dry, granulate and press tablets according to the method described in Example 1. A total of about 10,000 tablets were produced, each weighing 0.6g and containing ab...

Embodiment 3

[0032] Example 3: Analgin chewable tablets

[0033] Take 3300g starch, 3000g diazepam and 300g aspartame, and prepare mixture A according to the method described in Example 1. Put mixture A with 360 g of oral glucose, 1440 g of skimmed milk powder and 300 g of starch into a mixer and mix evenly to obtain mixture B, which is ready for use. Mix glycerin and anhydrous ethanol at a ratio of 1:10 and take 2.5L, add 200g of polyvinylpyrrolidone to it to prepare a polyvinylpyrrolidone glycerol-ethanol mixed solution as a binder.

[0034] Under stirring, add the polyvinylpyrrolidone glycerol-ethanol mixed solution to the mixture B in portions until all the additions are completed, and a soft material with uniform mixing and moderate humidity is obtained. Accurately weigh 30 g of magnesium stearate into granules, and granulate, dry, granulate and press tablets according to the method described in Example 1. A total of about 10,000 tablets were produced, each weighing 0.6g and containing ne...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an analgin chewable tablet used for dogs and cats. The invention overcomes the poor palatability defect of the existing tablet to promote the thorough chewing absorption by dogs and cats, so as to effectively guarantee the medicine-supply dose, to enhance the cure rate of diseases of dogs and cats and to reduce the medicine waste. The tablet of the invention comprises the following components represented by weight-percentage: 1 to 5 percent of aspartame; 20 to 30 percent of a mixture of oral dextrose and degreased milk powder; the ratio of 1:1 to 1:4 between the oral dextrose and degreased milk powder in the mixture; 40 to 60 percent of excipient; 0.5 to 1 percent of glidant and 30 to 50 percent of analgin.

Description

Technical field [0001] The invention relates to the preparation technology of veterinary drugs, in particular to a chewable tablet with good palatability for dogs and cats. Background technique [0002] Pet keeping has a long history in our country. With the improvement of living standards, the number of precious dogs, cats and pets has gradually increased, and pet owners have paid more and more attention to the quality of life of their pets. Dogs and cats are mammals and have their own common diseases. At present, the treatment of dog and cat diseases is mainly by intravenous drip and intramuscular injection. This kind of treatment plan often requires the owner to specially arrange time for the treatment of his pet. Interruption of treatment often results in a poor prognosis of the disease. If dogs and cats can take the initiative to take therapeutic drugs orally, this series of problems will be solved. However, the few veterinary tablets currently on the market are often diffic...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/4152A61K9/20A61K47/46A61P29/00
Inventor 李旭东鲍恩东苏建东
Owner TIANJIN RINGPU BIO TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com